WuXi PharmaTech (Cayman) Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f11f7fef-7ca9-4f25-b200-e8e063c52740/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $103.7M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-130264 |
| FY 2013 | $105.2M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-143458 |
| FY 2012 | $89.4M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-157991 |
| FY 2011 | $83.8M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-172679 |
| FY 2010 | $71.5M | 2010-01-01 – 2010-12-31 | evidence 0001193125-11-110537 |
| FY 2009 | $52.1M | 2009-01-01 – 2009-12-31 | evidence 0001193125-11-110537 |
| FY 2008 | $-20.9M | 2008-01-01 – 2008-12-31 | evidence 0001193125-11-110537 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).